Validation of an overactive bladder awareness tool for use in primary care settings

Abstract

Overactive bladder (OAB)--a syndrome characterized by urinary urgency, with or without urge incontinence, urinary frequency and nocturia--is estimated to affect 10% to 20% of the US and European populations. This study was carried out to validate a patient-administered screening awareness tool to identify patients with bothersome OAB symptoms. Patients were recruited from 12 primary care and 1 gynecology practice during regularly scheduled appointments. Enrollees completed an 8-item questionnaire assessing the amount of "bother" they associated with OAB symptoms. Clinicians then asked the patients 4 questions regarding urinary frequency, urgency, nocturia, and incontinence. If the screening was positive for symptoms of OAB or if the patient provided positive responses to the urinary symptom questions, the clinician asked additional questions regarding lifestyle and coping behaviors. The clinician then diagnosed the patient, placing him or her in the "No OAB," "Possible OAB," or "Probable OAB" category. Multivariable logistic regressions controlling for age and sex were performed to assess the applicability of the tool for identifying patients with OAB. A total of 1,299 patients were enrolled, and 1,260 provided complete data. Patients were aged 51.6+/-17.0 years, 62% were female, most (89%) were Caucasian, 22% experienced urinary urgency, and 18% experienced urge incontinence. The prevalence of Probable OAB was 12%. The c-index of the model identifying patients with a diagnosis of Probable OAB was 0.96, with a sensitivity and specificity of 98.0 and 82.7. For OAB-V8 scores >or=8, the odds ratio for Probable OAB was 95.7 (95% CI: 29.3; 312.4). The OAB-V8 performed well in helping clinicians identify patients with bothersome OAB symptoms in a primary care setting and will assist clinicians in identifying patients who may benefit from treatment.

A clinical perspective on electronically collecting patient-reported outcomes at the point-of-care for overactive bladder

“…This is consistent with observations from other studies involving PROs. 7,15,16 Participants also thought there to be several advantages to the digiPRO in assessing patients, adjusting a care plan, and preparing for patient care. Again, similar observations have been noted in other studies.…”

“…The system was comprised of two inter-related parts. The first part was the data capturing application, which included three PRO instruments: Overactive Bladder-8 (OAB-V8), 7 the International Prostate Symptom Score (IPSS), 8 and the Patient Perception of Bladder Condition (PPBC). 9 These instruments were selected because the paper-and-pencil formats were already being used in the clinic.…”

Relationship Between the Use of Diuretics and Overactive Bladder in Patients with Heart Failure

“…Therefore, combined diuretic use is common among heart failure patients. It has been estimated that OAB affects 10% to 20% of the US and European populations [3,8,12]. However, in heart failure populations this prevalence reaches to approximately 57% [5].…”

“…The OAB-V8 is a questionnaire designed for patients to determine the presence of OAB symptoms and how much the symptoms disturb the patients. This included eight questions regarding the symptoms of overactive bladder such as urinary frequency, nocturia, urgency and urge incontinence in order to assess the patients' symptoms [8]. Patients respond on a 6-point Likert scale ranging from 0 (not at all) to 5 (a very great deal), with a maximum possible score of 40.…”

Caracterização das disfunções miccionais em pacientes portadores do espectro da neuromielite óptica e suas associações com o comprometimento neurológico e a qualidade de vida

“…Apesar de também termos encontrado alta prevalência destes sintomas, nossos dados parecem estar mais próximos daqueles encontrados em pacientes portadores de EM, posto que a prevalência de cada um dos sintomas de esvaziamento avaliados no nosso estudo esteve entre 43-50%. O OAB-V8 foi inicialmente desenvolvido em inglês para identificar pacientes com Bexiga Hiperativa, para quantificar seus sintomas e para medir o impacto destes sobre a qualidade de vida de pacientes de ambos os sexos (72) . (106) .…”